Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W3168923313', 'doi': 'https://doi.org/10.1096/fasebj.2019.33.1_supplement.667.2', 'title': 'FPT, a Novel 5‐HT<sub>7</sub> and 5‐HT<sub>1A</sub> Partial Agonist, Treats Neuropsychiatric Symptoms Modeled in <i>Fmr1</i> Knockout Mice', 'display_name': 'FPT, a Novel 5‐HT<sub>7</sub> and 5‐HT<sub>1A</sub> Partial Agonist, Treats Neuropsychiatric Symptoms Modeled in <i>Fmr1</i> Knockout Mice', 'publication_year': 2019, 'publication_date': '2019-04-01', 'ids': {'openalex': 'https://openalex.org/W3168923313', 'doi': 'https://doi.org/10.1096/fasebj.2019.33.1_supplement.667.2', 'mag': '3168923313'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1096/fasebj.2019.33.1_supplement.667.2', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S25293849', 'display_name': 'The FASEB Journal', 'issn_l': '0892-6638', 'issn': ['0892-6638', '1530-6860'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5014437784', 'display_name': 'Jessica Armstrong', 'orcid': 'https://orcid.org/0000-0003-2456-3628'}, 'institutions': [{'id': 'https://openalex.org/I2801518522', 'display_name': 'Mercer University Health Sciences Center', 'ror': 'https://ror.org/01g67by91', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I2801518522']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Jessica Armstrong', 'raw_affiliation_strings': ['Pharmaceutical Sciences, Mercer University, Atlanta, GA'], 'affiliations': [{'raw_affiliation_string': 'Pharmaceutical Sciences, Mercer University, Atlanta, GA', 'institution_ids': ['https://openalex.org/I2801518522']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5060017380', 'display_name': 'Munmun Mukherjee', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I12912129', 'display_name': 'Northeastern University', 'ror': 'https://ror.org/04t5xt781', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I12912129']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Munmun Mukherjee', 'raw_affiliation_strings': ['Center for Drug Discovery, Northeastern University, Boston, MA'], 'affiliations': [{'raw_affiliation_string': 'Center for Drug Discovery, Northeastern University, Boston, MA', 'institution_ids': ['https://openalex.org/I12912129']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5081049479', 'display_name': 'Raymond G. Booth', 'orcid': 'https://orcid.org/0000-0003-2349-6400'}, 'institutions': [{'id': 'https://openalex.org/I12912129', 'display_name': 'Northeastern University', 'ror': 'https://ror.org/04t5xt781', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I12912129']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Raymond Booth', 'raw_affiliation_strings': ['Center for Drug Discovery, Northeastern University, Boston, MA'], 'affiliations': [{'raw_affiliation_string': 'Center for Drug Discovery, Northeastern University, Boston, MA', 'institution_ids': ['https://openalex.org/I12912129']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5091776135', 'display_name': 'Clinton E. Canal', 'orcid': 'https://orcid.org/0000-0002-7940-933X'}, 'institutions': [{'id': 'https://openalex.org/I2801518522', 'display_name': 'Mercer University Health Sciences Center', 'ror': 'https://ror.org/01g67by91', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I2801518522']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Clinton Canal', 'raw_affiliation_strings': ['Pharmaceutical Sciences, Mercer University, Atlanta, GA'], 'affiliations': [{'raw_affiliation_string': 'Pharmaceutical Sciences, Mercer University, Atlanta, GA', 'institution_ids': ['https://openalex.org/I2801518522']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 2, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 61}, 'biblio': {'volume': '33', 'issue': 'S1', 'first_page': None, 'last_page': None}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T12979', 'display_name': 'Cardiovascular Disease and Adiposity', 'score': 0.4731, 'subfield': {'id': 'https://openalex.org/subfields/2705', 'display_name': 'Cardiology and Cardiovascular Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T12979', 'display_name': 'Cardiovascular Disease and Adiposity', 'score': 0.4731, 'subfield': {'id': 'https://openalex.org/subfields/2705', 'display_name': 'Cardiology and Cardiovascular Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/fmr1', 'display_name': 'FMR1', 'score': 0.9843751}, {'id': 'https://openalex.org/keywords/fragile-x-syndrome', 'display_name': 'Fragile X Syndrome', 'score': 0.9535558}, {'id': 'https://openalex.org/keywords/knockout-mouse', 'display_name': 'Knockout mouse', 'score': 0.68917036}], 'concepts': [{'id': 'https://openalex.org/C2779063550', 'wikidata': 'https://www.wikidata.org/wiki/Q905435', 'display_name': 'FMR1', 'level': 4, 'score': 0.9843751}, {'id': 'https://openalex.org/C2777630245', 'wikidata': 'https://www.wikidata.org/wiki/Q221472', 'display_name': 'Fragile X syndrome', 'level': 2, 'score': 0.9535558}, {'id': 'https://openalex.org/C182704531', 'wikidata': 'https://www.wikidata.org/wiki/Q1364740', 'display_name': 'Knockout mouse', 'level': 3, 'score': 0.68917036}, {'id': 'https://openalex.org/C205778803', 'wikidata': 'https://www.wikidata.org/wiki/Q38404', 'display_name': 'Autism', 'level': 2, 'score': 0.5840539}, {'id': 'https://openalex.org/C2778938600', 'wikidata': 'https://www.wikidata.org/wiki/Q389934', 'display_name': 'Agonist', 'level': 3, 'score': 0.5581217}, {'id': 'https://openalex.org/C2775864247', 'wikidata': 'https://www.wikidata.org/wiki/Q167934', 'display_name': 'Serotonin', 'level': 3, 'score': 0.50117254}, {'id': 'https://openalex.org/C169760540', 'wikidata': 'https://www.wikidata.org/wiki/Q207011', 'display_name': 'Neuroscience', 'level': 1, 'score': 0.43614262}, {'id': 'https://openalex.org/C53910766', 'wikidata': 'https://www.wikidata.org/wiki/Q238516', 'display_name': '5-HT receptor', 'level': 4, 'score': 0.43470314}, {'id': 'https://openalex.org/C170493617', 'wikidata': 'https://www.wikidata.org/wiki/Q208467', 'display_name': 'Receptor', 'level': 2, 'score': 0.4291714}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.3630839}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.3594957}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.35807067}, {'id': 'https://openalex.org/C15744967', 'wikidata': 'https://www.wikidata.org/wiki/Q9418', 'display_name': 'Psychology', 'level': 0, 'score': 0.33542186}, {'id': 'https://openalex.org/C134018914', 'wikidata': 'https://www.wikidata.org/wiki/Q162606', 'display_name': 'Endocrinology', 'level': 1, 'score': 0.3324018}, {'id': 'https://openalex.org/C3020422209', 'wikidata': 'https://www.wikidata.org/wiki/Q221472', 'display_name': 'Fragile x', 'level': 3, 'score': 0.32343227}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.30775917}, {'id': 'https://openalex.org/C118552586', 'wikidata': 'https://www.wikidata.org/wiki/Q7867', 'display_name': 'Psychiatry', 'level': 1, 'score': 0.22631225}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.15374982}, {'id': 'https://openalex.org/C104317684', 'wikidata': 'https://www.wikidata.org/wiki/Q7187', 'display_name': 'Gene', 'level': 2, 'score': 0.0}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1096/fasebj.2019.33.1_supplement.667.2', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S25293849', 'display_name': 'The FASEB Journal', 'issn_l': '0892-6638', 'issn': ['0892-6638', '1530-6860'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.49, 'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being'}], 'grants': [{'funder': 'https://openalex.org/F4320306078', 'funder_display_name': 'U.S. Department of Defense', 'award_id': 'W81XWH‐17‐1‐0329'}, {'funder': 'https://openalex.org/F4320306123', 'funder_display_name': 'FRAXA Research Foundation', 'award_id': None}], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W4300497241', 'https://openalex.org/W2318063827', 'https://openalex.org/W2129698270', 'https://openalex.org/W2096167627', 'https://openalex.org/W2094168800', 'https://openalex.org/W2085938114', 'https://openalex.org/W2083700082', 'https://openalex.org/W2064588996', 'https://openalex.org/W1642338065', 'https://openalex.org/W1531946541'], 'abstract_inverted_index': {'Fragile': [0], 'X': [1], 'Syndrome': [2], '(FXS)': [3], 'is': [4, 364, 372], 'the': [5, 109, 114, 168, 257, 274, 282, 291, 366], 'leading': [6], 'monogenetic': [7], 'cause': [8], 'of': [9, 111, 116, 132, 150, 167, 276], 'intellectual': [10], 'disabilities': [11], 'and': [12, 17, 33, 73, 82, 92, 100, 160, 198, 221, 240, 242, 256, 284, 301, 342], 'autism.': [13, 83], 'Seizures,': [14], 'severe': [15], 'anxiety,': [16], 'sensory': [18], 'hypersensitivity': [19], 'are': [20, 37, 57], 'also': [21], 'common': [22], 'in': [23, 46, 98, 122, 201, 297, 323, 337, 382], 'FXS.': [24, 55, 133], 'The': [25, 383], 'central': [26], 'serotonin': [27, 35], 'system': [28], 'can': [29], 'modulate': [30], 'these': [31], 'symptoms,': [32], 'certain': [34], 'receptors': [36], 'functionally': [38], 'linked': [39], 'with': [40, 173, 326, 378], 'proteins': [41], 'known': [42], 'to': [43, 118, 141, 231, 269, 281, 349], 'be': [44, 52], 'altered': [45], 'FXS,': [47], 'suggesting': [48, 340], 'targeting': [49], 'them': [50], 'may': [51, 222], 'therapeutic': [53], 'for': [54, 80, 238, 245, 287], 'We': [56, 84, 226, 306], 'developing': [58], '(': [59], 'S': [60], ')‐5‐(2′‐Fluorophenyl)‐': [61], 'N,': [62], 'N': [63], '‐dimethyl‐1,2,3,4‐tetrahydronaphthalen‐2‐amine': [64], '(FPT),': [65], 'a': [66, 78, 142, 246], 'partial': [67], 'agonist': [68], 'at': [69], 'both': [70, 298], '5‐HT': [71, 74], '7': [72], '1A': [75], 'receptors,': [76], 'as': [77, 273], 'treatment': [79], 'FXS': [81, 99], 'previously': [85], 'reported': [86], 'that': [87, 216, 333, 345], 'FPT': [88, 117, 174, 188, 217, 293, 334], 'corrects': [89, 218], 'repetitive': [90, 219], 'behaviors': [91, 220], 'enhances': [93], 'social': [94, 233, 295], 'interactions—core': [95], 'symptom': [96], 'domains': [97], 'autism—in': [101], 'wild‐type': [102], '(WT)': [103], 'mouse': [104, 252, 280, 289], 'models.': [105], 'Herein,': [106], 'we': [107, 155], 'report': [108], 'results': [110], 'tests': [112], 'assessing': [113], 'efficacy': [115, 230], 'improve': [119], 'behavioral': [120, 311], 'phenotypes': [121], 'Fmr1': [123, 134, 152, 169, 202, 302, 350], 'knockout': [124], '(KO)': [125], 'mice,': [126], 'an': [127, 266], 'etiologically': [128], 'valid': [129], 'genetic': [130], 'model': [131], 'KO': [135, 153, 170, 203, 303, 351], 'mice': [136, 154, 171, 204, 324], 'have': [137, 223], 'seizures': [138], 'when': [139], 'exposed': [140], '120': [143], 'dB': [144], 'alarm': [145], '(audiogenic': [146], 'seizures,': [147], 'AGS).': [148], '73%': [149], 'vehicle‐treated': [151], 'tested': [156, 228], 'had': [157, 177], 'AGS': [158, 178], '(males': [159], 'females,': [161], 'age': [162], 'P23–25,': [163], 'N=22),': [164], 'however,': [165], '0%': [166], 'pretreated': [172], '(5.6': [175], 'mg/kg)': [176], '(N=20).': [179], 'This': [180, 362], 'effect': [181], 'was': [182, 253, 259, 271, 285], 'very': [183], 'significant': [184], '(P<0.0001).': [185], 'In': [186], 'addition,': [187], 'significantly': [189], 'reduced': [190, 199], 'marble': [191], 'burying': [192], '(vehicle,': [193, 205], 'N=11,': [194], 'FPT,': [195, 207], 'N=10,': [196], 'P<0.001)': [197], 'rearing': [200], 'N=12,': [206, 208], 'P<0.05).': [209], 'These': [210], 'data': [211, 329], 'corroborate': [212], 'our': [213], 'earlier': [214], 'studies': [215], 'anxiolytic': [224, 341], 'properties.': [225], 'next': [227], "FPT's": [229], 'promote': [232], 'behavior.': [234], 'Mice': [235], 'were': [236], 'matched': [237], 'genotype': [239], 'sex': [241], 'paired': [243], 'together': [244], '10': [247], 'minute': [248], 'observation': [249], 'period.': [250], 'One': [251], 'given': [254, 260], 'vehicle': [255], 'other': [258, 283], 'FPT.': [261, 327], 'Social': [262], 'behavior,': [263], 'scored': [264], 'by': [265], 'observer': [267], 'blind': [268], 'treatment,': [270], 'defined': [272], 'number': [275], 'approaches': [277], 'from': [278, 347, 365], 'one': [279], 'recorded': [286], 'each': [288], 'within': [290], 'pair.': [292], 'increased': [294], 'behavior': [296], 'WT': [299, 348], '(P<0.005)': [300], '(P<0.05)': [304], 'mice.': [305, 352], 'did': [307], 'not': [308], 'observe': [309], 'overt': [310], 'toxicity': [312], '(for': [313], 'example,': [314], 'hypolocomotion,': [315], 'flat': [316], 'body': [317], 'posture,': [318], 'tremor,': [319], 'or': [320, 354], 'head': [321], 'weaving)': [322], 'treated': [325], 'Our': [328], 'provide': [330], 'further': [331], 'evidence': [332], 'has': [335], 'activity': [336], 'neurobehavioral': [338], 'assays': [339], 'prosocial': [343], 'effects': [344], 'extend': [346], 'Support': [353], 'Funding': [355], 'Information': [356], 'DOD': [357], 'W81XWH‐17‐1‐0329,': [358], 'FRAXA': [359], 'Research': [360], 'Foundation': [361], 'abstract': [363, 380], 'Experimental': [367], 'Biology': [368], '2019': [369], 'Meeting.': [370], 'There': [371], 'no': [373], 'full': [374], 'text': [375], 'article': [376], 'associated': [377], 'this': [379], 'published': [381], 'FASEB': [384], 'Journal': [385], '.': [386]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W3168923313', 'counts_by_year': [], 'updated_date': '2024-12-07T17:56:02.069806', 'created_date': '2021-06-22'}